Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report TheLancet UCPH_Research semaglutide obesity adults treatment clinicaltrial trialnews
By Neha MathurJun 29 2023Reviewed by Lily Ramsey, LLM In a recent study published in The Lancet, researchers performed a phase III randomized clinical trial in nine countries across North America, Asia, and Europe to assess the effectiveness of semaglutide as the oral treatment of obesity in adults without type 2 diabetes .
It is given orally once daily at 7 mg and 14 mg doses for the treatment of T2D to improve glycaemic control and concurrently reduce body weight. Note that obesity treatment is key to the management of several obesity-related comorbidities. Next, the researchers evaluated two outcomes in parallel, i.e., coprimary endpoints. First, they determined the percentage change in body weight of all participants at week 68, even if they discontinued treatment or used other bodyweight-lowering therapies.
As confirmatory secondary endpoints, the team assessed whether participants attained at least 10%, 15%, and 20% bodyweight reduction till week 68 and reported any physical function outcomes, which included absolute body weight, BMI, waist circumference, blood pressure, glucose homeostasis changes, and glycaemic status.
The average body weight change from baseline to week 68 was 15·1% with oral semaglutide 50 mg vs. –2·4% with placebo. Most participants completed treatment by week 68, and 94% attended the end-of-trial visit at week 75, irrespective of treatment completion.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Intermittent fasting as effective as calorie counting for weight loss, study findsScientists from the University of Illinois Chicago studied 77 obese adults, putting them on three different diet plans. They found those who practised intermittent fasting lost just as much as those who were counting calories.
Read more »
Is COVID-19 severity of infection a new risk factor for chronic pain?Is COVID-19 severity of infection a new risk factor for chronic pain? PLOSONE UpstateNews StonyBrookMed chronicpain COVID19 coronavirus covid infection pain
Read more »
Insights into infant brain development: study shows how sound duration shapes auditory perceptionInsights into infant brain development: study shows how sound duration shapes auditory perception SciReports brain development childhealth auditory perception
Read more »
Beyond expectations: study finds treatment success gap in drug-resistant TuberculosisBeyond expectations: study finds treatment success gap in drug-resistant Tuberculosis AarhusUni_int TB tuberculosis drugresistance successgap treatment therapy
Read more »
Pictorial warnings pack a punch: Study finds decrease in parents' purchases of sugary drinks for kidsPictorial warnings pack a punch: Study finds decrease in parents' purchases of sugary drinks for kids PictorialWarnings HealthPromotion ChildHealth SugarSweetened Beverages ParentalBehavior Psychological Research PreventiveHealth BMC_series
Read more »
AI vs. human: Study shows ChatGPT falls short in accuracy and authenticity of scientific abstractsResearch investigates the use of large language models in scientific writing, finding that generated abstracts from ChatGPT are detected as 'fake' and raise concerns about accuracy and integrity. Ethical guidelines are needed to ensure proper use of language models in research.
Read more »